Losartan Potassium And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 16714-224

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Losartan Potassium And Hydrochlorothiazide (NDC 16714-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (50 mg/12.5 mg (30 Tablets Bottle))

Package Label-principal Display Panel (50 mg/12.5 mg (30 Tablets Bottle))
FDA Label Image

Package Label-principal Display Panel (100 mg/12.5 mg (30 Tablets Bottle))

Package Label-principal Display Panel (100 mg/12.5 mg (30 Tablets Bottle))
This text appears to be a description of a medication called Losartan Potassium and Hydrochlorothiazide, containing 100mg and 25mg respectively in a film-coated tablet form. The instructions mention the adult dosage, storage conditions, manufacturer details, and expiration date. The medication is packaged in a container with 30 tablets.*
FDA Label Image

Package Label-principal Display Panel (100 mg/25 mg (30 Tablets Bottle))

Package Label-principal Display Panel (100 mg/25 mg (30 Tablets Bottle))
This is a description of a medication called Losartan Potassium and Hydrochlorothiazide Tablets, USP with a dosage of 100 mg/25 mg. The package contains 30 tablets and should be stored at 20° to 25°C (68° to 77°F). The tablets are film-coated and each tablet contains Losartan potassium USP 100 mg and hydrochlorothiazide USP 25 mg. The usual adult dosage instructions can be found in the accompanying circular. The medication is manufactured for Northstar Rx LLC in Memphis, TN, and produced by APL Health Care Limited in India. The product is from India and was issued in July 2024.*
FDA Label Image

Losartan Chemical Structure (Losartanhctz Str1)

Losartan Chemical Structure (Losartanhctz Str1)
FDA Label Image

Hydrochlorothiazide Chemical Structure (Losartanhctz Str2)

Hydrochlorothiazide Chemical Structure (Losartanhctz Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.